COVID's long shadow: How SARS-CoV-2 infection, COVID-19 severity, and vaccination status affect long-term cognitive performance and health
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
38130975
PubMed Central
PMC10733723
DOI
10.1093/biomethods/bpad038
PII: bpad038
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, SARS-CoV-2, cognition, cognitive performance, long-term effects, mental health,
- Publikační typ
- časopisecké články MeSH
COVID-19 affects a variety of organs and systems of the body including the central nervous system. Recent research has shown that COVID-19 survivors often experience neurological and psychiatric complications that can last for months after infection. We conducted a large Internet study using online tests to analyze the effects of SARS-CoV-2 infection, COVID-19 severity, and vaccination on health, intelligence, memory, and information processing precision and speed in a cohort of 4445 subjects. We found that both SARS-CoV-2 infection and COVID-19 severity were associated with negative impacts on patients' health. Furthermore, we observed a negative association between COVID-19 severity and cognitive performance. Younger participants had a higher likelihood of SARS-CoV-2 contraction, while the elderly had a higher likelihood of severe COVID-19 and vaccination. The association between age and COVID-19 severity was primarily mediated by older participants' impaired long-term health. Vaccination was positively associated with intelligence and the precision of information processing. However, the positive association between vaccination and intelligence was likely mediated by achieved education, which was itself strongly associated with the likelihood of being vaccinated.
Zobrazit více v PubMed
Serrano-Castro PJ, Estivill-Torrús G, Cabezudo-García P. et al. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurologia (Engl Ed) 2020;35:245–51. PubMed PMC
Latifi A, Flegr J. Is recovery just the beginning? Persistent symptoms and health and performance deterioration in post-COVID-19, non-hospitalised university students—A cross-sectional study.Biology Methods and Protocols, 2023; bpad037. PubMed PMC
Kubota T, Kuroda N, Sone D.. Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin NeurosciNeurosci 2023;77:84–93. PubMed PMC
Wärnberg J, Gomez-Martinez S, Romeo J. et al. Nutrition, inflammation, and cognitive function. Ann N Y Acad Sci 2009;1153:164–75. PubMed
Demir B, Beyazyüz E, Beyazyüz M. et al. Long-lasting cognitive effects of COVID-19: is there a role of BDNF? Eur Arch Psychiatry Clin Neurosci 2022;273:1339–47. PubMed PMC
Herrera E, Gonzalez-Nosti M.. The effect of age on cognitive impairment associated with post COVID-19 syndrome. Psychiatry Res 2022;318:114945. PubMed PMC
Akinci B, Oğul OE, Hanoğlu L. et al. Evaluation of cognitive functions in adult individuals with COVID-19. Neurol Sci 2022;44:798–802. PubMed PMC
Zhou H, Lu S, Chen J. et al. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res 2020;129:98–102. PubMed PMC
Cavaco S, Sousa G, Gonçalves A. et al. Predictors of cognitive dysfunction one-year post COVID-19. Neuropsychology 37:557–67. PubMed
Miskowiak KW, Johnsen S, Sattler SM. et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol 2021;46:39–48. PubMed PMC
Cattell RB. Handbook for the Sixteen Personality Factors Questionnaire (16PF), Vol. 1. Carmel, IN: Institute for Personality and Ability Testing, 1970.
Meili R. Lehrbuch Der Psychologischen Diagnostik. Bern, Switzerland: Verlag Hans Huber, 1961.
Flegr J, Hampl R, Černochová D. et al. The relation of cortisol and sex hormone levels to results of psychological, performance, IQ and memory tests in military men and women. Neuroendocrinol Lett 2012;33:224–35. PubMed
Flegr J. Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study. Parasit Vectors 2021;14:508. PubMed PMC
Flegr J, Flegr P. Doing exploratory analysis in R with a package Explorer v. 1.0. Figshare, Digital Science, London, 2021. [10.6084/m9.figshare.14685825.v1]
Kim S. ppcor: an R package for a fast calculation to semi-partial correlation coefficients. Commun Stat Appl Methods 2015;22:665–74. PubMed PMC
Benjamini Y, Hochberg Y.. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995;57:289–300.
Rosseel Y. An R package for structural equation modeling. J Stat Soft 2012;48:1–36.
Epskamp S. semPlot: unified visualizations of structural equation models. Struct Equat Model Multidiscipl J 2015;22:474–83.
Flegr J. COVID2023CognitionData.csv Dataset. Figshare Digital Science, London. 2023. [doi.org/10.6084/m9.figshare.22586446.v1]
Evans RA, McAuley H, Harrison EM. et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021;9:1275–87. PubMed PMC
Shanbehzadeh S, Tavahomi M, Zanjari N. et al. Physical and mental health complications post-COVID-19: scoping review. J Psychosom Res 2021;147:110525. PubMed PMC
Hawlader MDH, Rashid MU, Khan MAS. et al. Quality of life of COVID-19 recovered patients in Bangladesh. PLoS One 2021;16:e0257421. PubMed PMC
Augustin M, Schommers P, Stecher M. et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021;6:100122. PubMed PMC
Zhao Y, Shi L, Jiang Z. et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol Psychiatry 2023;28:1793–801. PubMed PMC
Desai AD, Lavelle M, Boursiquot BC, Wan EY.. Long-term complications of COVID-19. Am J Physiol Cell Physiol 2022;322:C1–c11. PubMed PMC
Ali Awan H, Najmuddin Diwan M, Aamir A. et al. SARS-CoV-2 and the brain: what do we know about the causality of 'cognitive COVID? J Clin Med 2021;10:14. PubMed PMC
Del Brutto OH, Wu S, Mera RM. et al. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur J Neurol 2021;28:3245–53. PubMed PMC
Appelt PA, Sisconetto AT, Baldo Sucupira KSM. et al. Changes in electrical brain activity and cognitive functions following mild to moderate COVID-19: a one-year prospective study after acute infection. Clin EEG Neurosci 2022;53:543–57. PubMed PMC
Yildirim G. Evaluation of early cognitive functions in patients with COVID-19 infection. J Nerv Ment Dis 2022;210:912–4. PubMed PMC
Vannorsdall TD, Brigham E, Fawzy A. et al. Cognitive dysfunction, psychiatric distress, and functional decline after COVID-19. J Acad Consult Liaison Psychiatry 2022;63:133–43. PubMed PMC
Perrottelli A, Sansone N, Giordano GM. et al. Cognitive impairment after post-acute COVID-19 infection: a systematic review of the literature. J Pers Med 2022;12:18. PubMed PMC
Rizzo MR, Paolisso G.. SARS-CoV-2 emergency and long-term cognitive impairment in older people. Aging Dis 2021;12:345–52. PubMed PMC
Liu YH, Wang YR, Wang QH. et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener 2021;16:48. PubMed PMC
Liu YH, Chen Y, Wang QH. et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol 2022;79:509–17. PubMed PMC
Raveendran AV, Jayadevan R, Sashidharan S.. An overview. Diabetes Metab Syndr 2021;15:869–75. PubMed PMC
Silva Andrade B, Siqueira S, de Assis Soares WR. et al. Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses 2021;13:700. PubMed PMC
Ho FK, Petermann-Rocha F, Gray SR. et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS One 2020;15:e0241824. PubMed PMC
Liu K, Chen Y, Lin R. et al. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 2020;80:e14–e18. PubMed PMC
Bartleson JM, Radenkovic D, Covarrubias AJ. et al. SARS-CoV-2, COVID-19 and the ageing immune system. Nat Aging 2021;1:769–82. PubMed PMC
Sama IE, Voors AA.. Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome? Eur Heart J 2020;41:3096. PubMed PMC
Flegr J, Flegr P, Priplatova L.. The effects of 105 biological, socioeconomic, behavioral, and environmental factors on the risk of SARS-CoV-2 infection and a severe course of COVID-19: a prospective, explorative cohort study. Biol Methods Protoc 2022;7:15. PubMed PMC
Hanson SW, Abbafati C, Aerts JG. et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA-J Am Med Assoc 2022;328:1604–15. PubMed PMC
figshare
10.6084/m9.figshare.22586446.v1